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Abstract
Background: Coronaviruses have caused three outbreaks
in the past two decades. The novel one is SARS-COV-2,
which causes COVID-19. Pregnant women have a somewhat
altered immune state, which may make them more vulnerable to COVID-19 and its complications. Extensive research
is needed to better understand the clinical course of COVID19 in this population. This review article discusses the comparison of SARS-CoV-2 with previous coronavirus outbreaks,
clinical presentations, and complications in pregnant women
and newborns.
Methods: We conducted a literature search for case series
and case reports about pregnancy outcomes in pregnant
women with COVID-19 during the early phase of pandemic.
Results: In case series, 37 of 129 (28.6%) pregnant women

Introduction
COVID-19 disease is caused by the SARS-CoV-2 virus
which was first recognized in a cluster of pneumonia patients in China in December 2019.[1] As of early
August 2020, infected cases are exceeding 20 million
worldwide with more than 730 000 deaths.[2] Pregnant women’s health is an important issue which is still
under addressed in this pandemic as well as in previous outbreaks of SARS and MERS. Pneumonia due
to viral causes may have higher mortality and morbidity during pregnancy.[1] Physiologic changes that
occur during pregnancy are thought to affect pregnant women’s susceptibility to infection and clinical
severity of illness.[1] Previous epidemics have demonstrated how pregnant women are more susceptible to
infection and clinical severity, including the 1918-1919
influenza pandemic and the 1957-1958 Asian flu epidemic.[1] The case fatality rate for the 1918-1919 influenza pandemic was 27% and even higher when exULJRI | https://ir.library.louisville.edu/jri/vol4/iss1/74

with COVID-19 disease had preterm delivery, and 14 of 67
(20.9%) pregnant women had fetal distress. The rate of
preterm labor in normal pregnant women who are healthy and
not infected with any virus worldwide is approximately 11%.
Conclusion: Based on the articles reviewed, preterm delivery appears to be the most common complication in pregnant COVID-19 patients. Other complications include fetal
distress, stillbirth, intensive care unit (ICU) admission, and
severe disease leading to fetal demise and maternal mortality. Pregnancy outcomes seem to be better with COVID19 compared to SARS and MERS. However, most of these
publications are from the early part of the pandemic, when
protocols for the care of pregnant women were being developed and comprehensive knowledge of the disease process
in pregnant women was still a work in progress.

posure was in the 3rd trimester and the case fatality rate
for the Asian flu epidemic was twice as high as for infected pregnant women compared to women who were
not pregnant.[1] The swine-origin influenza A (H1N1)
virus also causes respiratory disease that also demonstrated higher susceptibility in pregnant women.[3] In
2009, during the H1N1 epidemic, pregnant women
were found to be at a higher risk of complications and
were four times more likely to be hospitalized than the
rest of the pregnant population.[3]
This review article discusses the comparison of previous coronavirus outbreaks, clinical presentations, and
complications in pregnant women and newborns.

Methods
On May 1st, 2020 we conducted a comprehensive literature search using PubMed and EMBASE. The search
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covered the articles on COVID-19 and pregnancy. The
following combinations of terms were used to find
the articles: COVID-19, COVID, pregnancy, maternal
complications, and neonatal complications. From the
search results, several case reports and series were
identified.
Inclusion criteria: Positive polymerase chain reaction
(PCR) or chest tomography (CT) was used to confirm
the diagnosis, the patient was pregnant at time of admission, article was written in English and clinical outcomes were mentioned.
Exclusion criteria: Article is not a case series or case
report, unable to obtain the full text, written in language other than English, COVID-19 suspected cases
without PCR or CT confirmation or unreported clinical
outcomes.

quired intensive care unit (ICU) admission and mechanical ventilation, death occurred in 7 patients. Out
of those 7 patients, 5 experienced worsening of the
disease after delivery. The other 2 had serious complications before delivery with intrauterine fetal death
(IUFD). The only 2 living patients were still hospitalized at the study time, one achieved slow recovery and
was extubated, but still hospitalized. The other one was
still critically ill and intubated.[6]
The neonatal outcomes are reported in Table 3. The
most common complication reported in the neonates
was low birth weight (LBW), defined as newborn birth
weight < 2500 g, reported in 14 out of 49 neonates.
LBW was seen with the preterm delivery (13/14 were
preterm and 1/14 was full term). Other complications
include stillbirth, rash and GI problems. Admission
to neonatal ICU and mechanical Ventilation (MV) were
also reported.

Results

Case Reports

Based on the results of the literature search, 9 case series and 6 case reports were included in this literature
review. For easy interpretation case series and case reports were summarized separately.

We collected 6 studies with a total 8 patients and 8
neonates delivered. Maternal age range was from 27
to 41. There were 3 twin sets with 2 sets delivered.
All patients were in the 3rd trimester. More details
about maternal characteristics are mentioned in Table
4. Laboratory findings include lymphopenia in all patients, and elevated liver enzymes in 3 out of 5 patients. There were no cases with gestational hypertension, preeclampsia or PROM.

Case Series
The clinical characteristics of mothers are reported in
Table 1. Overall, the total number of patients included
in the nine studies were 181. One hundred and thirtythree pregnant women were in the 3rd trimester, 26 in
the 2nd trimester and 22 in the 1st trimester. The maternal age ranges from 23 years old to 40 years old with
most of the patients below 35 years old. The diagnosis
was made using PCR, chest CT or both. CT findings included bilateral or unilateral patchy lung consolidation
or ground glass opacities. Underlying comorbidities
that presented before SARS-CoV-2 infection included
vaginal bleeding, cholecystitis, polycystic ovary syndrome and others. Laboratory findings included maternal lymphopenia, elevated AST and ALT.
The maternal clinical outcomes are reported in Table
2. The most common reported complication in mothers was preterm delivery defined as delivery before 37
weeks’ gestational age which presented in 37 out of 129
patients (28.68%). The second most reported complication was fetal distress that was reported in 14 out of
67 patients (20.89%). Cesarean section (CS) is the most
common reported mode of delivery (113/126 (89.68 %).
Lian Chen et al. reported 8 (57%) out of 14 preterm
delivery to be iatrogenic.[4] Now it is established that
COVID-19 infection is not an indication for CS, and in
fact it might increase the clinical deterioration in these
patients.[5]
Hantoushzadeh et al. reported 9 severe cases that reULJRI | https://ir.library.louisville.edu/jri/vol4/iss1/74

The maternal and neonatal complications are reported
in Table 5. The most common complication reported
was preterm delivery in 5 of 8 patients. Intensive care
unit (ICU) admission and mechanical ventilation occurred in 2 of 8 patients. Seven patients were delivered
by Cesarean section while one patient had a normal
vaginal delivery. No maternal mortality was reported.
There were two neonates admitted to a neonatal intensive care unit (NICU) with mechanical ventilation.
One of them intubated due to excessive sedation to the
mother. Those two neonates were born to the 2 mothers
admitted to ICU. No stillbirth, LBW, neonatal asphyxia
or death were reported.

Discussion
The following are lessons from previous coronaviruses
outbreaks:
Coronaviridae family
Coronaviridae is a large family that includes four
genera of coronaviruses Alphacoronavirus, Betacoronavirus, Deltacoronavirus, and Gammacoronavirus.
They are enveloped, single-stranded RNA viruses.
They infect a wide range of birds, animals, and hu2
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NA

NA

21/93

NA
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NA
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ALT elevated

30/121 (24.79%)

7/9

0

NA

NA

20/94

NA

0

NA

3

AST elevated

Abnormal laboratory findings
Maternal
lymphopenia (<1.0)

Gestational hypertension (1)
Pre-eclampsia (1)
PROM (2)

Comorbidities

Cholecystitis (1)

3rd

3rd

3rd

Trimester

Hypothyroidism (1)
Polycystic ovary syndrome (1)
Scarred uterus (3)

23-34

25-35

26-40

Age range

The median age was 31 years.
The author reported a 5-year range for each patient’s age to protect the patients’ identity.

181

9

Zhu et al.[21]

Total

9

No. of patients

Chen et al.[20]

Author

Table 1. Maternal clinical characteristics.
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Spontaneous (6)
Induced (8)

7

118
Delivered (68)

Yu et al.

181

9/178 (5.06%)

0

9
Delivered (7)
7

0

6

0

0

37/129 (28.68%)

Abbreviations: CS, Cesarean section; NVD, normal vaginal delivery.

Total

Hantoushzadeh et al.

0

5

0

13
Delivered (10)

Liu et al.

Chen et al.

0

7

0

Hu et al.

Chen et al.

0

0
Spontaneous (3)
Induced (4)
Ectopic (2)

4

6

Chen et al.

0

9

4

Preterm delivery

Zhu et al.

0

Abortion

9

No. of patients

Chen et al.

Author

14/67 (20.89%)

3

0

3

0

NA

0

0

6

2

Fetal distress

0

CS (3)
NVD (1)

9
11/63 (17.46%)

CS 113/126 (89.68%)
NVD 13/126 (10.32%)

0

CS (2)
NVD (3)
CS (6)
NVD (1)

1

0

CS (6)
NVD (1)
CS (10)

1

CS (63)
NVD (5)

0

0

CS (7)

0

CS

ICU admission

CS (7)
NVD (2)

Delivery mode

Table 2. Clinical outcomes in pregnant women with COVID-19.

10/63 (15.87%)

IMV (9)

0

ECMO (1)

0

NIMV

0

0

0

0

Mechanical
ventilation

7/181 (3.87%)

7

0

0

0

0

0

0

0

0

Maternal death
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Table 3. Neonatal outcomes in pregnant women with COVID-19.
n∗

Live birth

Still-birth

Neonatal demise

Low birth weight

NICU

Mech. vent.

Zhu et al.
Chen et al.
Yu et al.
Chen et al.
Hu et al.
Liu et al.
Chen et al.
Hantoushzadeh et al.

9 (1)
4
7
118 (2)
7
13
5
9 (3)

10
4
7
70
7
9
5
6

0
0
0
0
0
1
0
4

1
0
0
0
0
0
0
2

7
0
0
NA
0
NA
0
5

0
1
0
NA
0
NA
0
1

0
0
0
NA
0
NA
0
1

Total

181 (6)

127

5/187 (2.76%)

3/127 (2.36%)

14/49 (28.75%)

2/47 (4.26%)

1/47 (2.13%)

Author

Abbreviations: Mech. vent., mechanical ventilation; NICU, neonatal intensive care unit admission.
∗ Number of pregnant women (number of twin pregnancies).
Table 4. Maternal clinical characteristics.

Author

n

Cases

Maternal
age

Neonate
delivered

Trimester at
admission

Xia et al.[27]

1

1

27

yes

3rd

No

Alzamora et al.[28]

1

1

41

yes

3rd

Diabetes mellitus

Schnettler et al.[29]

1

1

39

yes

3rd

Mild myotonic dystrophy, bicuspid aortic valve, history of
2 previous low-transverse Cesarean deliveries, and
history of mildcerebrovascular accident

Koumoutsea et al.[30]

2

case 1

40

yes

3rd

Familial neutropenia, gestational diabetes mellitus,
HELLP syndrome

yes

3rd

Asthma and obesity

case 2
Fan et al.[31]

Total

2

Comorbidities

case 1

34

yes

3rd

No

case 2

29

yes

3rd

No

8

8

Abbreviations: HELLP: hemolysis, elevated liver enzymes, and low platelet count.

mans. There are seven species that cause human infection including endemic coronaviruses (4 species),
SARS, MERS and, recently, SARS-CoV-2. Their clinical manifestations range from mild to severe upper
and lower respiratory disease. SARS and MERS caused
significant outbreaks in 2002 and 2012 respectively.[1]
SARS, MERS and SarS-CoV-2 are under the genus betacoronavirus that might originate from bat virus. SARSCOV-2 shares 90% of the genetic material of bat virus
while SARS shares 80 % and MERS 50%.[3] Therefore
it is important to understand the effect of SARS and
MERS on pregnancy during previous epidemics in order to help predict SARS-COV-2 behavior and guide
the management of pregnancies until sufficient studies
and data about the novel coronavirus are available.
Pregnancy complications of SARS and MERS
Limited data about pregnant women with SARS or
MERS is available, so interpretation should be made
wisely. SARS was associated with worse clinical outULJRI | https://ir.library.louisville.edu/jri/vol4/iss1/74

comes in pregnant women than non-pregnant.[3] It
caused several adverse events like spontaneous abortion, intrauterine growth restriction (IUGR) IUGR and
severe maternal illness up to maternal death.[1] Maternal outcomes depended on the trimester of presentation.[7] Analysis suggests that pregnancy increases susceptibility to MERS and is associated with severe adverse outcomes with admission to ICU and death.[1]
Mortality rate of SARS infection during pregnancy was
25% and even higher in MERS infection.[3] There is no
vertical transmission noted in babies born to pregnant
women infected with SARS or MERS.[1] SARS-COV-2
seems to follow the same path according to the available information although few cases of COVID-19 infection have been reported in neonates born to COVID19 positive pregnant women. A large study was conducted in the UK on a national cohort of women in
which they reported 12 (5%) of 256 infants tested positive for SARS-CoV-2 with 6 of them within the first
12 hours of life.[8] Yet further investigation on vertical
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Table 5. Maternal and neonatal clinical outcomes.
Authors

Cases

Preterm

Maternal ICU and MV

Fetal distress

Delivery mode

Neonatal ICU

Neonatal MV

Iqbal et al.
Xia et al.
Alzamora et al.
Schnettler et al.
Koumoutsea et al.

1
1
1
1
Case 1
Case 2
Case 1
Case 2

No
No
Yes
Yes
Yes
Yes
No
Yes

No
No
Yes
Yes (ECMO)
No
No
No
No

No
Yes
No
No
No
Yes
No
No

NVD
CS
CS
CS
CS
CS
CS
CS

No
No
Yes
Yes
No
NA
No
No

No
No
Yes
Yes
No
NA
No
No

5/8

2/8

2/8

CS 7/8, NVD 1/8

2/7

2/7

Fan et al.
Total

Abbreviations: CS, Cesarean section; ICU, intensive care unit; MV, mechanical ventilation; NVD, normal vaginal delivery.

transmission is occurring to give more solid and accurate information.
Placental pathology of SARS
Only one study reported the pathology of placenta of
mothers with SARS, which showed variable findings
including increased subchorionic fibrin, fetal thrombotic vasculopathy and areas of avascular chorionic
villi.[9] These abnormalities suggest placental malperfusion. Interestingly, the placenta appeared normal in
pregnant women convalescing from SARS infection in
the first trimester. This is in stark contrast to those infected in the third trimester, as they showed extensive
placental pathology.[9] We did not find any available
published study about placental pathology of mothers
with MERS infection.
Clinical presentation and complications of COVID-19
SARS-COV-2 has an average incubation period of
about 5 days (2-14 days).[7] COVID -19 may present
with fever, cough, dyspnea, anosmia, fatigue, nausea,
loss of smell and taste, vomiting or diarrhea. Clinical presentation varies from asymptomatic to flu-like
symptoms, pneumonia, or ARDS and severe respiratory failure.[7] So far there is no evidence that pregnant
women have increased risk for COVID-19.[10] There
is no difference between pregnant and non-pregnant
women in terms of clinical course.[11] Despite that, Liu
H et al. noted a difference in laboratory values and
CT scan. They concluded an increase in leukocytosis and elevated neutrophil ratio in pregnant patients
compared to non-pregnant adults. Also, complete consolidation and mixed consolidation with ground glass
appearance were prevalent in pregnant cases in contrast to non-pregnant adults where pure ground glass
appearance was common.[12] The obstetric complications which have been reported include miscarriage,
preeclampsia, and Cesarean section with preterm birth
<37 weeks being the most common adverse event.[11]
However, one study found very good outcomes of
COVID-19 pregnant patients whom acquired the infection in late pregnancy.[13]
ULJRI | https://ir.library.louisville.edu/jri/vol4/iss1/74

In our review, incidence of preterm delivery was
28.68% and the incidence of fetal distress was 20.9%.
Not all preterm delivery was the result of fetal distress.
Some of the preterm deliveries were due to maternal
preference. The preterm delivery rate in the general
population is 11%.[14]
Although delivery through Cesarean section was reported as disproportionately high in these studies
(89.6%), not all Cesarean sections were performed due
to obstetric or fetal indications. The early Chinese
National Health commission guidelines favored CS to
normal vaginal delivery (NVD) in COVID-19 cases
due to fear and uncertainty about vertical transmission
risk.[15] Some of the pregnant women with COVID19 chose to be delivered before reaching term to proceed with further treatment for COVID-19 and/or to
avoid prolonged labor which was thought to be potentially detrimental for disease progression. Lack of
knowledge, uncertainty about the potential harmful
effect of COVID-19 to pregnant women and fetuses,
psychological stress and panic surrounding the pandemic might have contributed to the high Cesarean section rates and preterm deliveries. Even in the absence
of COVID-19, Cesarean sections due to maternal request are significantly higher in China compared to the
United states. The incidence of Cesarean delivery resulting from maternal request is estimated at 2.5% of all
births in the United States.[16] A retrospective cohort
study of 66,266 patients in mode of delivery in China
reported that 24.7% of women underwent Cesarean delivery due to maternal request.[17]
Another significant outcome seen in COVID-19 pandemic was low birth weight in (28.75%) of the babies
born to pregnant women with COVID-19 disease. This
number is like preterm delivery rate (28.68%) in these
studies which partially explains the low birth weight.
Although these reports from the early pandemic show
a grim outcome on Cesarean section rates, preterm deliveries and low birth weight babies, a few more recent studies from New York have shown more posi-
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tive results. A recent prospective study including 241
COVID-19 positive pregnant women in New York Hospitals showed that the rate of Cesarean birth was 41.5%
(100) overall, but only 10 (10%) of the Cesarean deliveries were performed for worsening maternal respiratory status. The incidence of preterm labor was
14.6% in this group of patients which is higher than
worldwide average of 11%, but significantly less than
preterm delivery rates reported earlier during the pandemic (28.6).[14] Furthermore, a report on pregnant
women with COVID-19 disease in New York that reported more than 1000 cases did not show significantly
increased C-section rates. Their Cesarean section rate
was 31% which is similar to national average.[18]

ACOG guidelines recommend that Cesarean section
should be reserved for obstetric indications and fetal indications, and that COVID-19 disease itself is not an indication for Cesarean section.[19] Adherence to ACOG
guidelines has helped prevent not only unindicated
preterm delivery and low birth weight babies but also
morbidity related to Cesarean section itself. Detection
of asymptomatic and mildly symptomatic COVID-19
disease because of the availability of test kits, confidence of health care providers in taking care of these
patients due to increasing information about the disease process also might explain less severe disease and
better outcomes in these more recent studies.
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